Trial intelligence / Profile preview

Effect of folic acid on myocardial perfusion scan in type 2 diabetic patients

IRCT2012120111624N1Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Oct 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of folic acid in coronary arteriosclerosis, atherosclerosis and type 2 diabetes mellitus (T2DM), sponsored by Tehran University of Medical Sciences. Primary endpoint: Myocardial perfusion scan findings. Started Oct 2012; status: completed.

02

Drugs

folic acid
03

Conditions

coronary arteriosclerosisatherosclerosistype 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on IRCT2012120111624N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2012120111624N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call